Home » Topics » BioWorld Science

BioWorld Science
RSS

New PROTAC induces degradation of hematopoietic prostaglandin D synthase

April 19, 2021

BOLD-100 shows robust preclinical efficacy against COVID-19 variants

April 19, 2021

NMPA of China approved IND application for HLX-26

April 19, 2021

First patients treated in phase I/II trial of pyrilutamide for acne in China

April 19, 2021

Phase III study of chiauranib in SCLC begins

April 19, 2021

GlaxoSmithKline begins phase I/II study of influenza vaccine candidate GSK-3206641A

April 19, 2021

Carrimycin studied in phase III to treat severe COVID-19 in hospitalized patients

April 19, 2021

Ideaya reports preliminary phase I/II data on darovasertib in metastatic uveal melanoma

April 16, 2021

Aussie researchers show critical role of DC-SCRIPT in producing key dendritic immune cells

April 16, 2021

Phase II trial of TQ-B3525 for advanced gynecological cancers begins enrollment

April 16, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...